Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 14 |
NetGPI | no | yes: 0, no: 14 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005730 | nucleolus | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 15 |
GO:0008541 | proteasome regulatory particle, lid subcomplex | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 8 |
GO:0043226 | organelle | 2 | 15 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 15 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 15 |
GO:0000502 | proteasome complex | 3 | 6 |
GO:0005634 | nucleus | 5 | 13 |
GO:0043227 | membrane-bounded organelle | 3 | 13 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 13 |
GO:0140535 | intracellular protein-containing complex | 2 | 6 |
GO:1902494 | catalytic complex | 2 | 6 |
GO:1905368 | peptidase complex | 3 | 6 |
GO:1905369 | endopeptidase complex | 4 | 6 |
Related structures:
AlphaFold database: E9AEZ8
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 2 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009057 | macromolecule catabolic process | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044248 | cellular catabolic process | 3 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 2 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
GO:1901575 | organic substance catabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 2 |
GO:0005515 | protein binding | 2 | 2 |
GO:0008047 | enzyme activator activity | 3 | 2 |
GO:0016504 | peptidase activator activity | 4 | 2 |
GO:0030234 | enzyme regulator activity | 2 | 2 |
GO:0032182 | ubiquitin-like protein binding | 3 | 2 |
GO:0043130 | ubiquitin binding | 4 | 2 |
GO:0044877 | protein-containing complex binding | 2 | 2 |
GO:0061133 | endopeptidase activator activity | 5 | 2 |
GO:0061134 | peptidase regulator activity | 3 | 2 |
GO:0061135 | endopeptidase regulator activity | 4 | 2 |
GO:0070628 | proteasome binding | 3 | 2 |
GO:0098772 | molecular function regulator activity | 1 | 2 |
GO:0140677 | molecular function activator activity | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 102 | 106 | PF00656 | 0.415 |
CLV_NRD_NRD_1 | 31 | 33 | PF00675 | 0.238 |
CLV_PCSK_KEX2_1 | 31 | 33 | PF00082 | 0.235 |
CLV_PCSK_PC1ET2_1 | 31 | 33 | PF00082 | 0.289 |
CLV_PCSK_SKI1_1 | 135 | 139 | PF00082 | 0.477 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.479 |
CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.214 |
DEG_APCC_DBOX_1 | 77 | 85 | PF00400 | 0.432 |
DEG_APCC_KENBOX_2 | 84 | 88 | PF00400 | 0.351 |
DEG_SPOP_SBC_1 | 153 | 157 | PF00917 | 0.545 |
DOC_MAPK_gen_1 | 124 | 131 | PF00069 | 0.586 |
DOC_MAPK_gen_1 | 143 | 150 | PF00069 | 0.511 |
DOC_MAPK_gen_1 | 31 | 38 | PF00069 | 0.435 |
DOC_MAPK_gen_1 | 63 | 70 | PF00069 | 0.481 |
DOC_PP4_FxxP_1 | 221 | 224 | PF00568 | 0.542 |
DOC_PP4_FxxP_1 | 7 | 10 | PF00568 | 0.535 |
DOC_PP4_MxPP_1 | 1 | 4 | PF00568 | 0.571 |
DOC_USP7_MATH_1 | 139 | 143 | PF00917 | 0.559 |
DOC_USP7_MATH_1 | 195 | 199 | PF00917 | 0.437 |
DOC_USP7_MATH_1 | 50 | 54 | PF00917 | 0.512 |
DOC_USP7_UBL2_3 | 100 | 104 | PF12436 | 0.499 |
DOC_USP7_UBL2_3 | 145 | 149 | PF12436 | 0.478 |
LIG_14-3-3_CanoR_1 | 124 | 130 | PF00244 | 0.541 |
LIG_14-3-3_CanoR_1 | 63 | 69 | PF00244 | 0.473 |
LIG_eIF4E_1 | 169 | 175 | PF01652 | 0.402 |
LIG_EVH1_2 | 3 | 7 | PF00568 | 0.538 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.602 |
LIG_FHA_1 | 149 | 155 | PF00498 | 0.492 |
LIG_FHA_1 | 199 | 205 | PF00498 | 0.554 |
LIG_FHA_1 | 74 | 80 | PF00498 | 0.446 |
LIG_LIR_Apic_2 | 219 | 224 | PF02991 | 0.447 |
LIG_LIR_Nem_3 | 132 | 137 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 212 | 217 | PF02991 | 0.384 |
LIG_SH2_CRK | 214 | 218 | PF00017 | 0.469 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.275 |
LIG_SH2_STAT5 | 177 | 180 | PF00017 | 0.599 |
LIG_SH2_STAT5 | 22 | 25 | PF00017 | 0.543 |
LIG_SH2_STAT5 | 35 | 38 | PF00017 | 0.507 |
LIG_SH2_STAT5 | 93 | 96 | PF00017 | 0.503 |
LIG_SH3_3 | 189 | 195 | PF00018 | 0.419 |
LIG_Sin3_3 | 200 | 207 | PF02671 | 0.397 |
LIG_WRC_WIRS_1 | 35 | 40 | PF05994 | 0.489 |
MOD_CK1_1 | 198 | 204 | PF00069 | 0.493 |
MOD_CK1_1 | 37 | 43 | PF00069 | 0.501 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.555 |
MOD_CK1_1 | 69 | 75 | PF00069 | 0.414 |
MOD_CK2_1 | 40 | 46 | PF00069 | 0.455 |
MOD_CK2_1 | 48 | 54 | PF00069 | 0.407 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.312 |
MOD_GlcNHglycan | 54 | 58 | PF01048 | 0.141 |
MOD_GSK3_1 | 137 | 144 | PF00069 | 0.506 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.289 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.529 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.498 |
MOD_NEK2_1 | 154 | 159 | PF00069 | 0.450 |
MOD_NEK2_1 | 20 | 25 | PF00069 | 0.535 |
MOD_NEK2_1 | 38 | 43 | PF00069 | 0.497 |
MOD_NEK2_2 | 34 | 39 | PF00069 | 0.466 |
MOD_PIKK_1 | 195 | 201 | PF00454 | 0.494 |
MOD_PIKK_1 | 69 | 75 | PF00454 | 0.483 |
MOD_Plk_1 | 104 | 110 | PF00069 | 0.287 |
MOD_Plk_4 | 104 | 110 | PF00069 | 0.403 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.461 |
MOD_Plk_4 | 154 | 160 | PF00069 | 0.461 |
MOD_Plk_4 | 216 | 222 | PF00069 | 0.546 |
MOD_Plk_4 | 34 | 40 | PF00069 | 0.448 |
MOD_Plk_4 | 66 | 72 | PF00069 | 0.509 |
MOD_SUMO_rev_2 | 132 | 137 | PF00179 | 0.580 |
MOD_SUMO_rev_2 | 142 | 151 | PF00179 | 0.609 |
MOD_SUMO_rev_2 | 99 | 106 | PF00179 | 0.519 |
TRG_ENDOCYTIC_2 | 214 | 217 | PF00928 | 0.443 |
TRG_ENDOCYTIC_2 | 35 | 38 | PF00928 | 0.519 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1T1 | Leptomonas seymouri | 65% | 99% |
A0A0S4KJ38 | Bodo saltans | 33% | 98% |
A0A1X0P5X9 | Trypanosomatidae | 30% | 89% |
A0A1X0P6U7 | Trypanosomatidae | 40% | 100% |
A0A3Q8IIY1 | Leishmania donovani | 95% | 100% |
A0A3R7K022 | Trypanosoma rangeli | 31% | 92% |
A0A422MVV1 | Trypanosoma rangeli | 40% | 100% |
A4HMJ8 | Leishmania braziliensis | 87% | 100% |
A4IB77 | Leishmania infantum | 95% | 100% |
C9ZZD7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 27% | 88% |
C9ZZK1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 97% |
E9B654 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
Q556N5 | Dictyostelium discoideum | 23% | 86% |
Q9Y7Y6 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 23% | 85% |
V5ATF0 | Trypanosoma cruzi | 36% | 100% |